Chromatin changes predict recurrence after radical prostatectomy

British Journal of Cancer

Volumn 114, Issue 11, 2016, Pages 1243-1250

  Hveem, Tarjei S ^a,b   Kleppe, Andreas ^a,b   Vlatkovic, Ljiljana ^a   Ersvær, Elin ^a,b   Wæhre, Hakon ^a,b   Nielsen, Birgitte ^a,b   Kjær, Marte Avranden ^a,b   Pradhan, Manohar ^a,b   Syvertsen, Rolf Anders ^a,b   Nesheim, John Arne ^a,b   Liestøl, Knut ^b   Albregtsen, Fritz ^a,b   Danielsen, Havard E ^a,b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

DNA ploidy; image cytometry; Nucleotyping; prognostic marker; prostate cancer; texture analysis

Indexed keywords

TUMOR MARKER; CHROMATIN;

ARTICLE; AUTOANALYSIS; CANCER PROGNOSIS; CANCER RECURRENCE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME ABERRATION; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; FOLLOW UP; GENETIC HETEROGENEITY; GLEASON SCORE; HUMAN; IMAGE CYTOMETRY; MALE; NUCLEOTYPING; PLOIDY; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; RISK ASSESSMENT; ADENOCARCINOMA; AGED; ANEUPLOIDY; CANCER GRADING; CELL NUCLEUS; CHROMATIN; COMPARATIVE STUDY; EPIDEMIOLOGY; GENETIC EPIGENESIS; GENETICS; IMAGE PROCESSING; METASTASIS; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TUMOR INVASION; TUMOR RECURRENCE; ULTRASTRUCTURE;

ADENOCARCINOMA; AGED; ANEUPLOIDY; CELL NUCLEUS; CHROMATIN; EPIGENESIS, GENETIC; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 84964553235     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.96     Document Type: Article

References (44)

1. Algaba F, Montironi R (2010) Impact of prostate cancer multifocality on its biology and treatment. J Endourol 24(5): 799-804.
2. Ambroise C, McLachlan GJ (2002) Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci USA 99(10): 6562-6566.
3. Andreoiu M, Cheng L (2010) Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol 41(6): 781-793.
4. Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Nordling S, Häggman M, Andersson S-O, Bratell S, Spangberg A, Palmgren J, Steineck G, Adami H-O, Johansson J-E (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364(18): 1708-1717.
5. Böcking A, Tils M, Schramm M, Dietz J, Biesterfeld S (2014) DNA-cytometric grading of prostate cancer Systematic review with descriptive data analysis. Pathol Discov 2(7).
6. Bottke D, Golz R, Storkel S, Hinke A, Siegmann A, Hertle L, Miller K, Hinkelbein W, Wiegel T (2013) Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis. Eur Urol 64(2): 193-198.
7. Cooperberg MR, Hilton JF, Carroll PR (2011) The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117(22): 5039-5046.
8. Cremer M, Kupper K, Wagler B, Wizelman L, von Hase J, Weiland Y, Kreja L, Diebold J, Speicher MR, Cremer T (2003) Inheritance of gene densityrelated higher order chromatin arrangements in normal and tumor cell nuclei. J Cell Biol 162(5): 809-820.
9. Danielsen HE, Pradhan M, Novelli M (2016) Revisiting tumour aneuploidy-The place of ploidy assessment in the molecular era. Nat Rev Clin Oncol 13(5): 291-304.
10. Duda RO, Hart PE, Stork DG (2000) Discriminant functions for the normal density. In Pattern Classification, 2nd edn, Chapter 2.6, pp 36-45. John Wiley & Sons: New York, NY, USA.
11. Dunn JM, Hveem T, Pretorius M, Oukrif D, Nielsen B, Albregtsen F, Lovat LB, Novelli MR, Danielsen HE (2011) Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett?s oesophagus. Br J Cancer 105(8): 1218-1223.
12. Epstein JI, Allsbrook Jr. WC, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29(9): 1228-1242.
13. Epstein JI, Srigley J, Grignon D, Humphrey P. Association of Directors of Anatomic and Surgical Pathology (2008) Recommendations for the reporting of prostate carcinoma. Am J Clin Pathol 129(1): 24-30.
14. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6): 1374-1403.
15. Harrell Jr. FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(18): 2543-2546.
16. Jorgensen T, Yogesan K, Tveter KJ, Skjorten F, Danielsen HE (1996) Nuclear texture analysis: a new prognostic tool in metastatic prostate cancer. Cytometry 24(3): 277-283.
17. Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, Trope CG, Danielsen HE (2003) Large-scale genomic instability predicts long-Term outcome for women with invasive stage I ovarian cancer. Ann Oncol 14(10): 1494-1500.
18. Leshner M, Devine M, Roloff GW, True LD, Misteli T, Meaburn KJ (2016) Locus-specific gene repositioning in prostate cancer. Mol Biol Cell 27(2): 236-246.
19. Melia J, Moseley R, Ball RY, Griffiths DF, Grigor K, Harnden P, Jarmulowicz M, McWilliam LJ, Montironi R, Waller M, Moss S, Parkinson MC (2006) A UK-based investigation of inter-And intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology 48(6): 644-654.
20. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341(24): 1781-1788.
21. Michiels S, Koscielny S, Hill C (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365(9458): 488-492.
22. Miller RG (1981) Simultaneous Statistical Inference, 2nd edn. Springer-Verlag New York, NY, USA.
23. Mohamed M, Greif PA, Diamond J, Sharafeldin O, Maxwell P, Montironi R, O'Brien A, Young M, Hamilton PW (2009) Changes in chromatin phenotype predict the response to hormonal deprivation therapy in patients with prostate cancer. BJU Int 103(3): 391-398.
24. Nielsen B, Albregtsen F, Danielsen HE (1999) The use of fractal features from the periphery of cell nuclei as a classification tool. Anal Cell Pathol 19(1): 21-37.
25. Nielsen B, Albregtsen F, Danielsen HE (2008) Statistical nuclear texture analysis in cancer research: a review of methods and applications. Crit Rev Oncog 14(2-3): 89-164.
26. Nielsen B, Albregtsen F, Kildal W, Abeler VM, Kristensen GB, Danielsen HE (2012) The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer. Anal Cell Pathol 35(4): 305-314.
27. Nielsen B, Albregtsen F, Kildal W, Danielsen HE (2001) Prognostic classification of early ovarian cancer based on very low dimensionality adaptive texture feature vectors from cell nuclei from monolayers and histological sections. Anal Cell Pathol 23(2): 75-88.
28. Nielsen B, Danielsen HE (2006) Prognostic value of adaptive textural features-The effect of standardizing nuclear first-order gray level statistics and mixing information from nuclei having different area. Cell Oncol 28(3): 85-95.
29. Nielsen B, Hveem TS, Kildal W, Abeler VM, Kristensen GB, Albregtsen F, Danielsen HE (2015) Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas. Cytometry A 87: 315-325.
30. Potter SR, Miller MC, Mangold LA, Jones KA, Epstein JI, Veltri RW, Partin AW (1999) Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology 54(5): 791-795.
31. Pretorius ME, Waehre H, Abeler VM, Davidson B, Vlatkovic L, Lothe RA, Giercksky KE, Danielsen HE (2009) Large scale genomic instability as an additive prognostic marker in early prostate cancer. Cell Oncol 31(4): 251-259.
32. Punnen S, Freedland SJ, Presti Jr. JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR (2014) Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol 65(6): 1171-1177.
33. Punt CJ, Buyse M, Kohne CH, Hohenberger P, Labianca R, Schmoll HJ, Pahlman L, Sobrero A, Douillard JY (2007) Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 99(13): 998-1003.
34. Schulerud H, Albregtsen F (2004) Many are called, but few are chosen. Feature selection and error estimation in high dimensional spaces. Comput Methods Programs Biomed 73(2): 91-99.
35. Schulerud H, Kristensen GB, Liestol K, Vlatkovic L, Reith A, Albregtsen F, Danielsen HE (1998) A review of caveats in statistical nuclear image analysis. Anal Cell Pathol 16(2): 63-82.
36. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED (2009) Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-Term followup of a randomized clinical trial. J Urol 181(3): 956-962.
37. Tilki D, Mandel P, Schlomm T, Chun FK, Tennstedt P, Pehrke D, Haese A, Huland H, Graefen M, Salomon G (2015) External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a european cohort. J Urol 193(6): 1970-1975.
38. Veltri RW, Khan MA, Miller MC, Epstein JI, Mangold LA, Walsh PC, Partin AW (2004) Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-Appearing and cancer peripheral zone epithelium in the prostate. Clin Cancer Res 10(10): 3465-3473.
39. Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26(6): 565-574.
40. Wei W, Ozolek JA, Slepc?ev D, Lee AB, Cheng C, Rohde GK (2011) An optimal transportation approach for nuclear structure-based pathology. IEEE Trans Med Imaging 30(3): 621-631.
41. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367(3): 203-213.
42. Yogesan K, Jorgensen T, Albregtsen F, Tveter KJ, Danielsen HE (1996) Entropy-based texture analysis of chromatin structure in advanced prostate cancer. Cytometry 24(3): 268-276.
43. Young IT, Verbeek PW, Mayall BH (1986) Characterization of chromatin distribution in cell nuclei. Cytometry 7(5): 467-474.
44. Zuleger N, Robson MI, Schirmer EC (2011) The nuclear envelope as a chromatin organizer. Nucleus 2(5): 339-349.